Cellular models and therapies for age-related macular degeneration

DMM Disease Models and Mechanisms

Volumn 8, Issue 5, 2015, Pages 421-427

  Forest, David L ^a   Johnson, Lincoln V ^a   Clegg, Dennis O ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

AMD; Cell culture models; HESC; IPSC; RPE; Stem cell therapy

Indexed keywords

AGE RELATED MACULAR DEGENERATION; CELL CULTURE; CELL DIFFERENTIATION; DRUG SCREENING; EXTRACELLULAR MATRIX; HUMAN; NONHUMAN; PHOTORECEPTOR; PHOTORECEPTOR CELL; PIGMENT EPITHELIUM; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STEM CELL TRANSPLANTATION; VISUAL IMPAIRMENT; ANIMAL; BIOLOGICAL MODEL; MACULAR DEGENERATION; PATHOLOGY;

ANIMALIA;

ANIMALS; HUMANS; MACULAR DEGENERATION; MODELS, BIOLOGICAL; STEM CELL TRANSPLANTATION;

EID: 84928994724     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.017236     Document Type: Review

References (92)

1. Ablonczy, Z., Dahrouj, M., Tang, P. H., Liu, Y., Sambamurti, K., Marmorstein, A. D. and Crosson, C. E. (2011). Human retinal pigment epithelium cells as functional models for the RPE in vivo. Invest. Ophthamol. Vis. Sci. 52, 8614-8620.
2. Abyzov, A., Mariani, J., Palejev, D., Zhang, Y., Haney, M. S., Tomasini, L., Ferrandino, A. F., Belmaker, L. A. R., Szekely, A., Wilson, M. et al. (2012). Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells. Nature 492, 438-442.
3. Adijanto, J. and Philip, N. J. (2014). Cultured primary human fetal retinal pigment epithelium (hfRPE) as a model for evaluating RPE metabolism. Exp. Eye. Res. 126, 77-84.
4. Ambati, J., Atkinson, J. and Gelfand, B. (2013). Immunology of age-related macular degeneration. Nat. Rev. 13, 438-451.
5. Amin, S., Chong, N. H. V., Bailey, T. A., Zhang, J., Knupp, C., Cheetham, M. E., Greenwood, J. and Luthert, P. J. (2004). Modulation of sub-RPE deposits in vitro: a potential model for age-related macular degeneration. Invest. Ophthamol. Vis. Sci. 45, 1281-1288.
6. Anderson, D. H., Radeke, M. J., Gallo, N. B., Chapin, E. A., Johnson, P. T., Curletti, C. R., Hancox, L. S., Hu, J., Ebright, J. N., Malek, G. et al. (2010). The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog. Retin. Eye Res. 29, 95-112.
7. Berman, K. and Brodaty, H. (2006). Psychosocial effects of age-related macular degeneration. Int. Psychogeriatr. 18, 415-428.
8. Bharti, K., Rao, M., Hull, S. C., Stroncek, D., Brooks, B. P., Feigal, E., van Meurs, J. C., Huang, C. A. and Miller, S. S. (2014). Developing cellular therapies for retinal degenerative diseases. Invest. Ophthamol. Vis. Sci. 55, 1191-1202.
9. Bock, C., Kiskinis, E., Verstappen, G., Gu, H., Boulting, G., Smith, Z., Ziller, M., Croft, G. F., Amoroso, M. W., Oakley, D. H. et al. (2011). Reference maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell 144, 439-452.
10. Booij, J. C., Baas, D. C., Beisekeeva, J., Gorgels, T. G. M. F. and Bergen, A. A. B. (2010). The dynamic nature of Bruch's membrane. Prog. Retin. Eye Res. 29, 1-18.
11. Buchholz, D. E., Hikita, S. T., Rowland, T. J., Friedrich, A. M., Hinman, C. R., Johnson, L. V. and Clegg, D. O. (2009). Derivation of functional retinal pigmented epithelium from induced pluripotent stem cells. Stem Cells 27, 2427-2434.
12. Carlson, C., Koonce, C., Aoyama, N., Einhorn, S., Fiene, S., Thompson, A., Swanson, B., Anson, B. and Kattman, S. (2013). Phenotypic screening with human iPS cell-derived cardiomyocytes: HTS-compatible assays for interrogating cardiac hypertrophy. J. Biomol. Screen. 18, 1203-1211.
13. Carr, A.-J., Vugler, A. A., Hikita, S. T., Lawrence, J. M., Gias, C., Chen, L. L., Buchholz, D. E., Ahmado, A., Semo, M., Smart, M. J. K. et al. (2009). Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat. PLoS ONE 4, e8152.
14. Carr, A.-J. F., Smart, M. J. K., Ramsden, C. M., Powner, M. B., da Cruz, L. and Coffey, P. J. (2013). Development of human embryonic stem cell therapies for age-related macular degeneration. Trends Neurosci. 36, 385-395.
15. Coffey, P. (2012). Untapping the potential of human retinal pigmented epithelial cells. Cell Stem Cell 10, 1-2.
16. Cristofalo, V. and Pignolo, R. (1995). Chapter 4: Cell culture as a model. In Handbook of Physiology Sect 11: Aging (ed. Masoro E. J.), pp. 53-82. American Physiological Society: New York.
17. Croze, R. H. and Clegg, D. O. (2014). Differentiation of pluripotent stem cells into retinal pigmented epithelium. Dev. Opthalmol. 53, 81-96.
18. Curcio, C. and Johnson, M. (2013). Structure, function, and pathology of Bruch's membrane. Chapter 20. In Retina, Vol. 1, 5th edn (ed. Ryan et al.), pp. 465-481. Elsevier/Saunders: Philadelphia.
19. Cyranoski, D. (2014). Japanese woman is first recipient of next-generation stem cells. Nature (12 September 2014).
20. Demontis, F., Piccirillo, R., Goldberg, A. L. and Perrimon, N. (2013). Mechanisms of skeletal muscle aging: insights from Drosophila and mammalian models. Dis. Model. Mech. 6, 1339-1352.
21. Diniz, B., Thomas, P., Thomas, B., Ribeiro, R., Hu, Y., Brant, R., Ahuja, A., Zhu, D., Liu, L., Koss, M. et al. (2013). Subretinal implantation of retinal pigment epithelial cells derived fromhuman embryonic stem cells: improved survival when implanted as a monolayer. Invest. Ophthalmol. Vis. Sci. 54, 5087-5096.
22. Dunn, K. C., Aotaki-Keen, A. E., Putkey, F. R. and Hjelmeland, L. M. (1996). ARPE-19, A human retinal pigment epithelial cell line with differentiated properties. Exp. Eye Res. 62, 155-170.
23. Eiraku, M. and Sasai, Y. (2012). Mouse embryonic stem cell culture for generation of three-dimensional retinal and cortical tissues. Nat. Protoc. 7, 69-79.
24. Enzmann, V., Yolcu, E., Kaplan, H. J. and Ildstad, S. T. (2009). Stem cells as tools in regenerative therapy for retinal degeneration. Arch. Ophthalmol. 127, 563-571.
25. Feigl, B. and Hutmacher, D. (2013). Eyes on 3D-Current 3D biomimetic disease concept models and potential applications in age-related macular degeneration. Adv. Healthc. Mater. 2, 1056-1062.
26. Ford, K. M., Saint-Geniez, M., Walshe, T. E. and D'Amore, P. A. (2012). Expression and role of VEGF-A in the ciliary body. Invest. Ophthamol. Vis. Sci. 53, 7520-7527.
27. Gamm, D. M., Phillips, M. J. and Singh, R. (2013). Modeling retinal degenerative diseases with human iPS-derived cells: current status and future implications. Expert Rev. Ophthalmol. 8, 213-216.
28. Gorham, R. D., Forest, D. L., Tamamis, P., López de Victoria, A., Kraszni, M., Kieslich, C. A., Banna, C. D., Bellows-Peterson, M. L., Larive, C. K., Floudas, C. A. et al. (2013). Novel compstatin family peptides inhibit complement activation by drusen-like deposits in human retinal pigmented epithelial cell cultures. Exp. Eye Res. 116, 96-108.
29. Hageman, G. S., Anderson, D. H., Johnson, L. V., Hancox, L. S., Taiber, A. J., Hardisty, L. I., Hageman, J. L., Stockman, H. A., Borchardt, J. D., Gehrs, K. M. et al. (2005). A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc. Natl. Acad. Sci. USA 102, 7227-7232.
30. Hamilton, R. D. and Leach, L. (2011). Isolation and properties of an in vitro human outer blood-retinal barrier model. Methods Mol. Biol. 686, 401-416.
31. Hewitt, A. and Adler, R. (1989). The retinal pigment epithelium and interphotoreceptor matrix: structure and function. Chapter 6. In Retina, Vol. 1: Basic Science and Inherited Retinal Disease (ed. T. Ogden), pp. 57-64. St Louis: The C.V. Mosby Company.
32. Hirami, Y., Osakada, F., Takahashi, K., Okita, K., Yamanaka, S., Ikeda, H., Yoshimura, N. and Takahashi, M. (2009). Generation of retinal cells frommouse and human induced pluripotent stem cells. Neurosci. Lett. 458, 126-131.
33. Hornof, M., Toropainen, E. and Urtti, A. (2005). Cell culture models of the ocular barriers. Eur. J. Pharm. Biopharm. 60, 207-225.
34. Hu, Y., Liu, L., Lu, B., Zhu, D., Ribero, R., Diniz, B., Thomas, P. B., Ahuja, A. K., Hinton, D. R., Tai, Y.-C. et al. (2012). A novel approach for subretinal implantation of ultrathin substrates containing stem cell-derived retinal pigment epithelium monolayer. Ophthalmic Res. 48, 186-191.
35. Idelson, M., Alper, R., Obolensky, A., Ben-Shushan, E., Hemo, I., Yachimovich-Cohen, N., Khaner, H., Smith, Y., Wiser, O., Gropp, M. et al. (2009). Directed differentiation of human embryonic stem cells into functional retinal pigment epithelium cells. Cell Stem Cell 5, 396-408.
36. Jakobsdottir, J., Conley, Y. P., Weeks, D. E., Ferrell, R. E. and Gorin, M. B. (2008). C2 and CFB genes in age-related maculopathy and joint action with CFH and LOC387715 genes. PLoS ONE 3, e2199.
37. Jin, Z.-B., Okamoto, S., Osakada, F., Homma, K., Assawachananont, J., Hirami, Y., Iwata, T. and Takahashi, M. (2011). Modeling retinal degeneration using patient-specific induced pluripotent stem cells. PLoS ONE 6, e17084.
38. Johnson, L. V., Leitner, W. P., Staples, M. K. and Anderson, D. H. (2001). Complement activation and inflammatory processes in drusen formation and age related macular degeneration. Exp. Eye Res. 73, 887-896.
39. Johnson, L. V., Forest, D. L., Banna, C. D., Radeke, C. M., Maloney, M. A., Hu, J., Spencer, C. N., Walker, A. M., Tsie, M. S., Bok, D. et al. (2011). Cell culture model that mimics drusen formation and triggers complement activation associated with age-related macular degeneration. Proc. Natl. Acad. Sci. USA 108, 18277-18282.
40. Kamao, H., Mandai, M., Okamoto, S., Sakai, N., Suga, A., Sugita, S., Kiryu, J. and Takahashi, M. (2014). Characterization of human induced pluripotent stem cell-derived retinal pigment epithelium cell sheets aiming for clinical application. Stem Cell Rep. 2, 205-218.
41. Kawa, M. P., Machalinska, A., Roginska, D. and Machalinski, B. (2014). Complement system in pathogenesis of AMD: dual player in degeneration and protection of retinal tissue. J. Immunol. Res. 2014, 1-12.
42. Klimanskaya, I., Hipp, J., Rezai, K. A., West, M., Atala, A. and Lanza, R. (2004). Derivation and comparative assessment of retinal pigment epithelium from human embryonic stem cells using transcriptomics. Cloning Stem Cells 6, 217-245.
43. Kokkinaki, M., Sahibzada, N. and Golestaneh, N. (2011). Human induced pluripotent stem-derived retinal pigment epithelium (RPE) cells exhibit ion transport, membrane potential, polarized vascular endothelial growth factor secretion, and gene expression pattern similar to native RPE. Stem Cells 29, 825-835.
44. Krohne, T. U., Westenskow, P. D., Kurihara, T., Friedlander, D. F., Lehmann, M., Dorsey, A. L., Li, W., Zhu, S., Schultz, A., Wang, J. et al. (2012). Generation of retinal pigment epithelial cells from small molecules and OCT4 reprogrammed human induced pluripotent stem cells. Stem Cells Transl. Med. 1, 96-109.
45. Kvanta, A. and Grudzinska, M. K. (2014). Stem cell-based treatment in geographic atrophy: promises and pitfalls. Acta Ophthamol. 92, 21-26.
46. Lehr, C. M. (2005). Cell culture models and nanobiotechnology - contemporary topics in advanced drug delivery research. Eur. J. Pharm. Biopharm. 60, v-vi.
47. Liu, Z., Yu, N., Holz, F. G., Yang, F. and Stanzel, B. V. (2014). Enhancement of retinal pigment epithelial culture characteristics and subretinal space tolerance of scaffolds with 200 nm fiber topography. Biomaterials 35, 2837-2850.
48. Lu, B., Malcuit, C., Wang, S., Girman, S., Francis, P., Lemieux, L., Lanza, R. and Lund, R. (2009). Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration. Stem Cells 27, 2126-2135.
49. Lu, B., Zhu, D., Hinton, D., Humayun, M. S. and Tai, Y.-C. (2012). Mesh-supported submicron parylene-C membranes for culturing retinal pigmented epithelial cells. Biomed. Microdevices 14, 659-667.
50. Lund, R. D., Wang, S., Klimanskaya, I., Holmes, T., Ramos-Kelsey, R., Lu, B., Girman, S., Bischoff, N., Sauvé, Y. and Lanza, R. (2006). Human embryonic stem-cell derived cells rescue visual function in dystrophic RCS rats. Cloning Stem Cells 8, 189-199.
51. Mack, D. L., Guan, X., Wagoner, A., Walker, S. J. and Childers, M. K. (2014). Disease-in-a-Dish: the contribution of patient-specific induced pluripotent stem cell technology to regenerative rehabilitation. Am. J. Phys. Med. Rehabil. 93, S155-S168.
52. Maminishkis, A., Chen, S., Jalickee, S., Banzon, T., Shi, G., Wang, F., Ehalt, T., Hammer, J. and Miller, S. (2006). Confluent monolayers of cultured human fetal retinal pigment epithelium exhibit morphology and physiology of native tissue. Invest. Ophthamol. Vis. Sci. 47, 3612-3624.
53. Maruotti, J., Wahlin, K., Gorrell, D., Bhutto, I., Lutty, G. and Zack, D. J. (2013). A simple and scalable process for the differentiation of retinal pigment epithelium from human pluripotent stem cells. Stem Cells Transl. Med. 2, 341-354.
54. McCarty, C. A., Mukesh, B. N., Fu, C. L., Mitchell, P., Wang, J. J. and Taylor, H. R. (2001). Risk factors for age-related maculopathy. Arch. Ophthalmol. 119, 1455-1462.
55. McHugh, K. J., Tao, S. L. and Saint-Geniez, M. (2014). Porous poly(∈- caprolactone) scaffolds for retinal pigment epithelium transplantation. Invest. Ophthamol. Vis. Sci. 55, 1754-1762.
56. Meyer, J. S., Howden, S. E., Wallace, K. A., Verhoeven, A. D., Wright, L. S., Capowski, E. E., Pinilla, I., Martin, J. M., Tian, S., Stewart, R. et al. (2011). Optic vesicle-like structures derived from human pluripotent stem cells facilitate a customized approach to retinal disease treatment. Stem Cells 29, 1206-1218.
57. Nakano, T., Ando, S., Takata, N., Kawada, M., Muguruma, K., Sekiguchi, K., Saito, K., Yonemura, S., Eiraku, M. and Sasai, Y. (2012). Self-formation of optic cups and storable stratified neural retina from human ESCs. Cell Stem Cell 10, 771-785.
58. Nakatsuji, N., Nakajima, F. and Tokunaga, K. (2008). HLA-haplotype banking and iPS cells. Nat. Biotechnol. 26, 739-740.
59. Nasonkin, I. O., Merbs, S. L., Lazo, K., Oliver, V. F., Brooks, M., Patel, K., Enke, R. A., Nellissery, J., Jamrich, M., Le, Y. Z. et al. (2013). Conditional knockdown of DNA methyltransferase 1 reveals a key role of retinal pigment epithelium integrity in photoreceptor outer segment morphogenesis. Development 140, 1330-1341.
60. Pampaloni, F., Reynaud, E. G. and Stelzer, E. H. K. (2007). The third dimension bridges the gap between cell culture and live tissue. Nat. Rev. Mol. Cell Biol. 8, 839-845.
61. Pennesi, M. E., Neuringer, M. and Courtney, R. J. (2012). Animal models of age related macular degeneration. Mol. Aspects Med. 33, 487-509.
62. Pera, M. F. (2011). Stem cells: the dark side of induced pluripotency. Nature 471, 46-47.
63. Pfeffer, B. A. (1991). Improved methodology for cell culture of human and monkey retinal pigment epithelium. Prog. Retin. Eye Res. 10, 251-291.
64. Phillips, M. J., Perez, E. T., Martin, J. M., Reshel, S. T., Wallace, K. A., Capowski, E. E., Singh, R., Wright, L. S., Clark, E. M., Barney, P. M. et al. (2014). Modeling human retinal development with patient-specific induced pluripotent stem cells reveals multiple roles for Visual System Homeobox 2. Stem Cells 32, 1480-1492.
65. Rabin, D., Rabin, R., Blenkinsop, T., Temple, S. and Stern, J. (2013). Chronic oxidative stress upregulates Drusen-related protein expression in adult human RPE stem cell-derived RPE cells: a novel culture model for dry AMD. Aging 5, 51-66.
66. Radu, R. A., Hu, J., Jiang, Z. and Bok, D. (2014). Bisretinoid-mediated complement activation on retinal pigment epithelial cells is dependent on Complement Factor H haplotype. J. Biol. Chem. 289, 9113-9120.
67. Ratner, M. (2014). Next-generation AMD drugs to wed blockbusters. Nat. Biotechnol. 32, 701-702.
68. Raya, A., Rodriguez-Piza, I., Guenechea, G., Vassena, R., Navarro, S., Barrero, M. J., Consiglio, A., Castellà, M., Río, P., Sleep, E. et al. (2009). Diseasecorrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature 460, 53-59.
69. Rohrer, B., Long, Q., Coughlin, B., Renner, B., Huang, Y., Kunchithapautham, K., Ferreira, V. P., Pangburn, M. K., Gilkeson, G. S., Thurman, J. M. et al. (2010). A targeted inhibitor of the complement alternative pathway reduces RPE injury and angiogenesis in models of age-related macular degeneration. Adv. Exp. Med. Biol. 703, 137-149.
70. Rowland, T. J., Blaschke, A. J., Buchholz, D. E., Hikita, S. T., Johnson, L. V. and Clegg, D. O. (2013). Differentiation of human pluripotent stem cells to retinal pigmented epithelium in defined conditions using purified extracellular matrix proteins. J. Tissue Eng. Regen. Med. 7, 642-653.
71. Saint-Geniez, M., Maharaj, A. S. R., Walshe, T. E., Tucker, B. A., Sekiyama, E., Kurihara, T., Darland, D. C., Young, M. J. and D'Amore, P. A. (2008). Endogenous VEGF is required for visual function: evidence for a survival role on Müller cells and photoreceptors. PLoS ONE 3, e3554.
72. Salero, E., Blenkinsop, T. A., Corneo, B., Harris, A., Rabin, D., Stern, J. H. and Temple, S. (2012). Adult human RPE can be activated into a multipotent stem cell that produces mesenchymal derivatives. Cell Stem Cell 10, 88-95.
73. Schwartz, S. D., Hubschman, J.-P., Heilwell, G., Franco-Cardenas, V., Pan, C. K., Ostrick, R. M., Mickunas, E., Gay, R., Klimanskaya, I. and Lanza, R. (2012). Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet 379, 713-720.
74. Schwartz, S. D., Regillo, C. D., Lam, B. L., Eliott, D., Rosenfeld, P. J., Gregori, N. Z., Hubschman, J.-P., Davis, J. L., Heilwell, G., Spirn, M. et al. (2015). Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt'smacular dystrophy: follow-up of two open-label phase 1/2 studies. Lancet 385, 509-516.
75. Selvaraj, V., Plane, J. M., Williams, A. J. and Deng, W. (2010). Switching cell fate: the remarkable rise of induced pluripotent stem cells and lineage reprogramming technologies. Trends Biotechnol. 28, 214-223.
76. Shadforth, A. M. A., George, K. A., Kwan, A. S., Chirila, T. V. and Harkin, D. G. (2012). The cultivation of human retinal pigment epithelial cells on Bombyx mori silk fibroin. Biomaterials 33, 4110-4117.
77. Sheridan, C. (2014). Stem cell therapy clears first hurdle in AMD. Nat. Biotechnol. 32, 1173-1174.
78. Singh, R., Shen, W., Kuai, D., Martin, J. M., Guo, X., Smith, M. A., Perez, E. T., Phillips, M. J., Simonett, J. M., Wallace, K. A. et al. (2013). iPS cell modeling of Best disease: insights into the pathophysiology of an inherited macular degeneration. Hum. Mol. Genet. 22, 593-607.
79. Sonoda, S., Spee, C., Barron, E., Ryan, S. J., Kannan, R. and Hinton, D. R. (2009). A protocol for the culture and differentiation of highly polarized human retinal pigment epithelial cells. Nat. Protoc. 4, 662-673.
80. Sorkio, A., Hongisto, H., Kaarniranta, K., Uusitalo, H., Juui-Uusitalo, K. and Skottman, H. (2014). Structure and barrier properties of human embryonic stem cell-derived retinal pigment epithelial cells are affected by extracellular matrix protein coating. Tissue Eng. 20, 622-634.
81. Stanzel, B.V., Liu, Z., Somboonthanakij, S., Wongsawad, W., Brinken, R., Eter, N., Corneo, B., Holz, F. G., Temple, S., Stern, J. H. et al. (2014). Human RPE stem cells grown into polarized RPE monolayers on a polyester matrix are maintained after grafting into rabbit subretinal space. Stem Cell Rep. 2, 64-77.
82. Sunness, J. (1999). Geographic atrophy. Chapter 7. In Age-related Macular Degeneration (eds J. W. Berger, S. L. Fine and M. G. Maguire), pp. 155-166. St Louis: The C.V. Mosby Company.
83. Takahashi, K. and Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676.
84. Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S. and Jones, J. M. (1998). Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147.
85. Wahlin, K. J., Maruotti, J., and Zack, D. J. (2014). Modeling retinal dystrophies using patient-derived induced pluripotent stem cells.. Adv. Exp. Med. Biol. 801, 157-164.
86. Westenskow, P. D., Kurihara, T., and Friedlander, M. (2014). Utilizing stem cellderived RPE cells as a therapeutic intervention for age related macular degeneration.. Adv. Exp. Med. Biol. 801, 323-329.
87. Williams, D. and Burke, J. (1990). Modulation of growth in retina-derived cells by extracellular matrices. Invest. Ophthamol. Vis. Sci. 31, 1717-1723.
88. Yabut, O. and Bernstein, H. (2011). The promise of human embryonic stem cells in aging-associated diseases. Aging 3, 494-508.
89. Yang, J., Li, Y., Chan, L., Tsai, Y.-T., Wu, W.-H., Nguyen, H. V., Hsu, C.-W., Li, X., Brown, L. M., Egli, D. et al. (2014). Validation of genome-wide association study (GWAS)-identified disease risk alleles with patient-specific stem cell lines. Hum. Mol. Genet. 23, 3445-3455.
90. Yates, J. R. W., Sepp, T., Matharu, B. K., Khan, J. C., Thurlby, D. A., Shahid, H., Clayton, D. G., Hayward, C., Morgan, J., Wright, A. F. et al. (2007). Complement C3 variant and the risk of age-related macular degeneration. N. Engl. J. Med. 357, 553-561.
91. Zeiss, C. J. (2010). Animals as models of age-related macular degeneration: an imperfect measure of the truth. Vet. Pathol. 47, 396-413.
92. Zhong, X., Gutierrez, C., Xue, T., Hampton, C., Vergara, M. N., Cao, L.-H., Peters, A., Park, T. S., Zambidis, E. T., Meyer, J. S. et al. (2014). Generation of threedimensional retinal tissue with functional photoreceptors from human iPSCs. Nat. Commun. 5, 4047.